TNFSF10 and colorectal carcinoma: Taken together, the present study demonstrates the antitumour activity of TRAIL in a cytotoxicity (SuperKiller TRAIL) assay and xenograft models (Killer TRAIL) of primary CRC after i.v. administration, which was correlated to DR upregulation and provides estimates of the disposition of TRAIL in humans.